Literature DB >> 29977390

Synthesis of pyrazolopyrimidinones using a "one-pot" approach under microwave irradiation.

Mark Kelada1, John M D Walsh1, Robert W Devine1, Patrick McArdle2, John C Stephens1.   

Abstract

A simple one-pot method for the microwave-assisted synthesis of substituted pyrazolo[1,5-a]pyrimidinones, a core scaffold in many bioactive and pharmaceutically relevant compounds, has been established. A variety of substituents was tolerated at the 2 and 5 positions, including functionalized aryls, heterocycles, and alkyl groups.

Entities:  

Keywords:  microwave-assisted synthesis; nitrogen-fused heterocycle; one-pot; pyrimidinone

Year:  2018        PMID: 29977390      PMCID: PMC6009099          DOI: 10.3762/bjoc.14.104

Source DB:  PubMed          Journal:  Beilstein J Org Chem        ISSN: 1860-5397            Impact factor:   2.883


Introduction

The pyrazolo[1,5-a]pyrimidinone is a fused nitrogen-containing heterocyclic system and is of interest due to its role as a basic core scaffold in many bioactive and pharmaceutically relevant compounds, as well as its structural similarity to purine [1-4]. Pyrazolo[1,5-a]pyrimidinone derivatives have found use in the battle against several illnesses including cancer [5], viral infections [6-8], obesity [9], and cystic fibrosis [10] (Figure 1). It is these pharmacological properties, coupled with the pharmaceutical and fine chemical industries interest in synthetic processes that utilize cleaner and more efficient technology, which has stimulated the search for improved synthetic procedures for their generation.
Figure 1

Bioactive pyrazolo[1,5-a]pyrimidinones.

Bioactive pyrazolo[1,5-a]pyrimidinones. Consequently, strategies for the synthesis of compounds of value, such as the pyrazolo[1,5-a]pyrimidinones, that employ one-pot syntheses and/or processes have been encouraged and have become a major focus for many synthetic chemists [11]. As such, a convenient and general method of preparing the scaffold would be of significant interest to the pharmaceutical industry. Herein, we report such a strategy for the simple synthesis of functionalized pyrazolo[1,5-a]pyrimidinones that employs a one-pot microwave-assisted approach.

Findings

A number of synthetic approaches have been developed for the synthesis of privileged nitrogen-fused bicyclic systems such as the pyrazolo[3,4-b]pyridines, pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidinones [12-18]. The majority of methods used in the generation of the pyrazolo[1,5-a]pyrimidinones employ a two-step process, which first requires the synthesis and isolation of the intermediate 5-aminopyrazoles followed by their reaction with an appropriate β-dicarbonyl compound [1-419-29]. A very recent and excellent review by Aggarwal et al. covers the use and versatility of 5-aminopyrazoles in the synthesis of a range of pyrazoloazines [30]. As part of a study into the development of novel biologically active compounds based on the pyrazolopyrimidinone scaffold, we sought to develop a simple one-pot synthesis of the nitrogen-fused bicyclic system. In order to establish reaction conditions for this one-pot synthesis, we began by seeking general reaction conditions for the microwave-assisted generation of the intermediate 5-aminopyrazoles. Once established, this methodology could be expanded to generate a one-pot synthesis of pyrazolo[1,5-a]pyrimidinones. Typical methods for preparing 5-aminopyrazoles require conventional heating of the appropriate β-ketonitrile in the presence of a hydrazine [1-419-29], with Rao et al. [31] and Bagley et al. [32] reporting microwave-assisted protocols, the former requiring an acid catalyst. In order to conduct a solvent screen we chose β-ketonitrile 1a as a model substrate and reacted it with hydrazine, employing a constant temperature of 150 °C and a reaction time of 5 min. Results from the solvent screen can be found in Table 1, with high isolated yields of the product 5-aminopyrazole 2a in all cases. As expected, a significant improvement in reaction time was observed under microwave conditions in comparison with conventional heating (Table 1, entries 7, 8 and 9). Methanol was subsequently selected as the solvent of choice, due to the higher yield generated and its lower cost when compared with acetonitrile. Temperature and time were then varied with the best combination of temperature and time found to be 150 °C for 5 min (Table 2, entry 5).
Table 1

Solvent screen for the synthesis of 5-aminopyrazole 2a.a


EntryHeating methodSolventYieldb %

1MWDCM82
2MWtoluene83
3MWPet ether88
4MWEtOAc92
5MWMeCN96
6MWpetroleum ether/MeOH 9:199
7MWMeOH99
8cconvent.MeOH60
9dconvent.MeOH30

aReaction conditions: ketonitrile (0.9 mmol, 1.0 equiv), hydrazine (1.2 mmol, 1.3 equiv), solvent (1 mL) were heated under microwave conditions (100 W, 150 °C) for 5 min. bIsolated yield. cReaction conditions: ketonitrile (0.9 mmol, 1.0 equiv), hydrazine (1.2 mmol, 1.3 equiv), solvent (1 mL) were heated under conventional heating conditions at reflux for 17 h. dReaction conditions: ketonitrile (0.9 mmol, 1.0 equiv), hydrazine (1.2 mmol, 1.3 equiv), solvent (1 mL) were heated under conventional heating conditions at reflux for 5 min.

Table 2

Temperature and time variations for the synthesis of 5-aminopyrazole 2a.a

EntryT (°C)Time (min)Yieldb %

11204084
21303096
3130553
41402098
5150599

aReaction conditions: ketonitrile (0.9 mmol, 1.0 equiv), hydrazine (1.2 mmol, 1.3 equiv), MeOH (1 mL) were heated under microwave conditions (100 W). bIsolated yield.

Solvent screen for the synthesis of 5-aminopyrazole 2a.a aReaction conditions: ketonitrile (0.9 mmol, 1.0 equiv), hydrazine (1.2 mmol, 1.3 equiv), solvent (1 mL) were heated under microwave conditions (100 W, 150 °C) for 5 min. bIsolated yield. cReaction conditions: ketonitrile (0.9 mmol, 1.0 equiv), hydrazine (1.2 mmol, 1.3 equiv), solvent (1 mL) were heated under conventional heating conditions at reflux for 17 h. dReaction conditions: ketonitrile (0.9 mmol, 1.0 equiv), hydrazine (1.2 mmol, 1.3 equiv), solvent (1 mL) were heated under conventional heating conditions at reflux for 5 min. Temperature and time variations for the synthesis of 5-aminopyrazole 2a.a aReaction conditions: ketonitrile (0.9 mmol, 1.0 equiv), hydrazine (1.2 mmol, 1.3 equiv), MeOH (1 mL) were heated under microwave conditions (100 W). bIsolated yield. A substrate scope study showed that a variety of substituents is tolerated. Aromatic groups with electron-withdrawing and electron-donating substituents at the ortho, meta and para positions were successfully explored (Scheme 1). The heterocyclic furan and thiophene substituents allowed generation of the desired 5-aminopyrazoles in 75% and 81% yields, respectively (Scheme 1). Alkyl groups appeared to be less well tolerated, where the corresponding alkyl-substituted 5-aminopyrazoles were isolated in lower yields.
Scheme 1

Synthesis of 5-aminopyrazoles. Reaction conditions: ketonitrile (2.0 mmol, 1.0 equiv), hydrazine (2.6 mmol, 1.3 equiv), MeOH (1 mL) were heated under microwave conditions (100 W, 150 °C) for 5 min. Isolated yields.

Synthesis of 5-aminopyrazoles. Reaction conditions: ketonitrile (2.0 mmol, 1.0 equiv), hydrazine (2.6 mmol, 1.3 equiv), MeOH (1 mL) were heated under microwave conditions (100 W, 150 °C) for 5 min. Isolated yields. With a convenient and general microwave-assisted method for the synthesis of the 5-aminopyrazoles in hand, we next focused our attention on its application to the one-pot synthesis of pyrazolo[1,5-a]pyrimidinones. The synthesis of pyrazolo[1,5-a]pyrimidinone 3a was chosen as the model reaction (Scheme 2). Initial reaction conditions were chosen to match the already developed microwave-assisted synthesis of the 5-aminopyrazoles. A solution of the β-ketonitrile in methanol was treated with hydrazine and heated to 150 °C under microwave irradiation for 5 min. The β-ketoester and acetic acid were then simply added to the pot and the reaction heated at the same temperature, 150 °C, under microwave irradiation for a further 2 h. The target pyrazolo[1,5-a]pyrimidinone was subsequently isolated in an overall yield of 52%. Once more, a significant improvement was observed using microwave conditions in comparison with conventional heating.
Scheme 2

One-pot synthesis of pyrazolo[1,5-a]pyrimidinones. aReaction conditions: ketonitrile (0.9 mmol, 1.0 equiv), hydrazine (1.2 mmol, 1.3 equiv), MeOH (1 mL) were heated under microwave conditions (100 W, 150 °C) for 5 min followed by the addition of AcOH (0.5 mmol, 0.6 equiv) and ketoester (0.9 mmol, 1.0 equiv) and heated under microwave conditions (100 W, 150 °C) for a further 2 h. bIsolated yield. cReactions conditions: isolated aminopyrazole (0.9 mmol, 1.0 equiv), AcOH (0.5 mmol, 0.6 equiv), ketoester (0.9 mmol, 1.0 equiv) in methanol (2 mL) were heated using conventional heating conditions at reflux for 18 h. dReactions conditions: isolated aminopyrazole (0.9 mmol, 1.0 equiv), AcOH (0.5 mmol, 0.6 equiv), ketoester (0.9 mmol, 1.0 equiv) in methanol (2 mL) were heated using conventional heating conditions at reflux for 2 h.

One-pot synthesis of pyrazolo[1,5-a]pyrimidinones. aReaction conditions: ketonitrile (0.9 mmol, 1.0 equiv), hydrazine (1.2 mmol, 1.3 equiv), MeOH (1 mL) were heated under microwave conditions (100 W, 150 °C) for 5 min followed by the addition of AcOH (0.5 mmol, 0.6 equiv) and ketoester (0.9 mmol, 1.0 equiv) and heated under microwave conditions (100 W, 150 °C) for a further 2 h. bIsolated yield. cReactions conditions: isolated aminopyrazole (0.9 mmol, 1.0 equiv), AcOH (0.5 mmol, 0.6 equiv), ketoester (0.9 mmol, 1.0 equiv) in methanol (2 mL) were heated using conventional heating conditions at reflux for 18 h. dReactions conditions: isolated aminopyrazole (0.9 mmol, 1.0 equiv), AcOH (0.5 mmol, 0.6 equiv), ketoester (0.9 mmol, 1.0 equiv) in methanol (2 mL) were heated using conventional heating conditions at reflux for 2 h. When a mixture of previously isolated 5-aminopyrazole 2a, β-ketoester, and acetic acid were heated under conventional refluxing conditions for 18 h, the product pyrazolo[1,5-a]pyrimidinone 3a could only be isolated in a 25% yield. As expected, heating the reaction mixture for 2 h at reflux gave a lower isolated yield of 11%. A one-pot procedure under conventional refluxing conditions was also carried out in direct comparison with the microwave method, i.e., a solution of the β-ketonitrile in methanol was treated with hydrazine and refluxed for 5 min. The β-ketoester and acetic acid were then added to the pot and the reaction refluxed for a further 2 h. A complex mixture resulted consisting mostly of starting β-ketonitrile. The superior performance of the microwave reaction, in terms of yield and reaction time, could result from the higher temperature and pressure achieved. The substrate scope for the one-pot reaction was then explored, with variations of both R1 and R2 groups at the pyrazolo[1,5-a]pyrimidinone core (Scheme 2). Pyrazolo[1,5-a]pyrimidinones containing aromatic groups with electron-withdrawing and electron-donating substituents at the ortho, meta and para positions were generated, including the multi-substituted 3n, as were those with heterocyclic furyl and thienyl substituents (Scheme 2). Alkyl-substituted pyrazolo[1,5-a]pyrimidinones were also synthesized using this one-pot method (Scheme 2). The structures of the pyrazolo[1,5-a]pyrimidinones were characterized using 1H and 13C NMR spectral data, HRMS, and IR spectroscopy. In addition, an X-ray crystal structure was obtained for pyrazolo[1,5-a]pyrimidinone 3m and is shown in Figure 2.
Figure 2

X-ray crystal structure of pyrazolo[1,5-a]pyrimidinone 3m with ellipsoids at 50% probability.

X-ray crystal structure of pyrazolo[1,5-a]pyrimidinone 3m with ellipsoids at 50% probability.

Conclusion

In conclusion, we have developed a new facile method for the one-pot microwave-assisted synthesis of substituted pyrazolo[1,5-a]pyrimidinones, a core scaffold in many bioactive and pharmaceutically relevant compounds. A variety of functional groups was tolerated at the 2 and 5 positions, including functionalized aryls, heterocycles, and alkyl groups. Furthermore, an efficient and general microwave-assisted synthesis of versatile 5-aminopyrazoles is reported.

Supporting Information

CCDC-1588686 contains the crystallographic data for 3m. The data can be obtained from The Cambridge Crystallographic Data Centre (CCDC) via http://www.ccdc.cam.ac.uk/data_request/cif. Experimental section, NMR spectra of all synthesized compounds and crystallographic data of compound 3m.
  17 in total

1.  Synthesis of pyrazolo[1,5-alpha]pyrimidinone regioisomers.

Authors:  Lori K Gavrin; Arthur Lee; Brian A Provencher; Walter W Massefski; Stephen D Huhn; Gregory M Ciszewski; Derek C Cole; John C McKew
Journal:  J Org Chem       Date:  2007-02-02       Impact factor: 4.354

2.  Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonists.

Authors:  D J Wustrow; T Capiris; R Rubin; J A Knobelsdorf; H Akunne; M D Davis; R MacKenzie; T A Pugsley; K T Zoski; T G Heffner; L D Wise
Journal:  Bioorg Med Chem Lett       Date:  1998-08-18       Impact factor: 2.823

3.  Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators.

Authors:  Jinlong Qi; Fan Zhang; Yi Mi; Yan Fu; Wen Xu; Diqun Zhang; Yibing Wu; Xiaona Du; Qingzhong Jia; Kewei Wang; Hailin Zhang
Journal:  Eur J Med Chem       Date:  2011-01-22       Impact factor: 6.514

4.  IND-2, a pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinoline derivative, circumvents multi-drug resistance and causes apoptosis in colon cancer cells.

Authors:  Chandrabose Karthikeyan; Crystal Lee; Joshua Moore; Roopali Mittal; Esther A Suswam; Kodye L Abbott; Satyanarayana R Pondugula; Upender Manne; Narayanan K Narayanan; Piyush Trivedi; Amit K Tiwari
Journal:  Bioorg Med Chem       Date:  2014-12-08       Impact factor: 3.641

5.  Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetes.

Authors:  Robert P Brigance; Wei Meng; Aberra Fura; Thomas Harrity; Aiying Wang; Robert Zahler; Mark S Kirby; Lawrence G Hamann
Journal:  Bioorg Med Chem Lett       Date:  2010-06-15       Impact factor: 2.823

6.  Identification of potent, selective KDM5 inhibitors.

Authors:  Victor S Gehling; Steven F Bellon; Jean-Christophe Harmange; Yves LeBlanc; Florence Poy; Shobu Odate; Shane Buker; Fei Lan; Shilpi Arora; Kaylyn E Williamson; Peter Sandy; Richard T Cummings; Christopher M Bailey; Louise Bergeron; Weifeng Mao; Amy Gustafson; Yichin Liu; Erica VanderPorten; James E Audia; Patrick Trojer; Brian K Albrecht
Journal:  Bioorg Med Chem Lett       Date:  2016-07-19       Impact factor: 2.823

7.  Lead optimization of a pyrazolo[1,5-a]pyrimidin-7(4H)-one scaffold to identify potent, selective and orally bioavailable KDM5 inhibitors suitable for in vivo biological studies.

Authors:  Jun Liang; Birong Zhang; Sharada Labadie; Daniel F Ortwine; Maia Vinogradova; James R Kiefer; Victor S Gehling; Jean-Christophe Harmange; Richard Cummings; Tommy Lai; Jiangpeng Liao; Xiaoping Zheng; Yichin Liu; Amy Gustafson; Erica Van der Porten; Weifeng Mao; Bianca M Liederer; Gauri Deshmukh; Marie Classon; Patrick Trojer; Peter S Dragovich; Lesley Murray
Journal:  Bioorg Med Chem Lett       Date:  2016-06-29       Impact factor: 2.823

8.  Synthesis and antischistosomal activity of certain pyrazolo[1,5-a]pyrimidines.

Authors:  K Senga; T Novinson; H R Wilson; R K Robins
Journal:  J Med Chem       Date:  1981-05       Impact factor: 7.446

9.  Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor.

Authors:  Jong Yeon Hwang; Marc Peter Windisch; Suyeon Jo; Keumhyun Kim; Sunju Kong; Hyoung Cheul Kim; Soohyun Kim; Heeyoung Kim; Myung Eun Lee; Youngmi Kim; Jihyun Choi; Dong-Sik Park; Eunjung Park; Jeongjin Kwon; Jiyoun Nam; Sujin Ahn; Jonathan Cechetto; Junwon Kim; Michel Liuzzi; Zaesung No; Jinhwa Lee
Journal:  Bioorg Med Chem Lett       Date:  2012-11-05       Impact factor: 2.823

10.  Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization.

Authors:  Candice Soares de Melo; Soares de Melo Candice; Tzu-Shean Feng; Renier van der Westhuyzen; Richard K Gessner; Leslie J Street; Garreth L Morgans; Digby F Warner; Atica Moosa; Krupa Naran; Nina Lawrence; Helena I M Boshoff; Clifton E Barry; C John Harris; Richard Gordon; Kelly Chibale
Journal:  Bioorg Med Chem       Date:  2015-10-22       Impact factor: 3.641

View more
  2 in total

1.  Three-Component Coupling of Aldehydes, Aminopyrazoles, and Sulfoxonium Ylides via Rhodium(III)-Catalyzed Imidoyl C-H Activation: Synthesis of Pyrazolo[1,5- a]pyrimidines.

Authors:  Gia L Hoang; Andrew D Streit; Jonathan A Ellman
Journal:  J Org Chem       Date:  2018-12-10       Impact factor: 4.354

Review 2.  Effects of Linkers and Substitutions on Multitarget Directed Ligands for Alzheimer's Diseases: Emerging Paradigms and Strategies.

Authors:  Narayanaperumal Pravin; Krzysztof Jozwiak
Journal:  Int J Mol Sci       Date:  2022-05-29       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.